Back to search

Sweden· SE-20110825000056

Bosulif 100 mg Filmdragerad tablett

A medicinal product containing bosutinib, registered in Sweden by Pfizer Europe MA EEIG.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedBosulif 100 mg Filmdragerad tablettATC—REGISTER NO.SE-20110825000056PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Bosutinib
Manufacturer
Pfizer Europe MA EEIG
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20110825000056

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bosutinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bosutinib products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Bosutinib Sandoz, Bosutinib Teva
  • Belgium · Bosutinib Eg, Bosutinib Eg (Eurogeneric)
  • Bulgaria · Босутиниб Msn, Босутиниб Зентива
  • Czechia · Bosutinib Msn, Bosutinib Teva
  • Germany · Bosutinib, Bosutinib Al
  • Denmark · Bosutinib Newbury, Bosutinib Sandoz
  • Estonia · Bosutinib Msn
  • Spain · Bosutinib, Bosutinib Vivanta
  • Finland · Bosutinib Stada
  • France · Bosutinib Biogaran, Bosutinib Eg Labo
  • United Kingdom (Northern Ireland) · Bosutinib Dr. Reddy’s, Bosutinib Stada
  • Croatia · Bosutinib Msn, Bosutinib Onkogen
  • Hungary · Bosutinib Onkogen, Bosutinib Sandoz
  • Ireland · Bosutinib Clonmel, Bosutinib Rowex
  • Iceland · Bosulif, Bosutinib Beta
  • Italy · Bosutinib Dr. Reddys, Bosutinib Eg
  • Liechtenstein · Bosulif
  • Lithuania · Bosutinib Msn
  • Luxembourg · Bosutinib Eg
  • Latvia · Bosutinib Msn
  • Malta · Bosutinib, Bosutinib Lotus
  • Netherlands · Bosutinib, Bosutinib Cf
  • Norway · Bosulif, Bosutinib Newbury
  • Poland · Bosutinib Msn, Bosutinib Onkogen
  • Portugal · Bosutinib Teva
  • Romania · Bosutinib Teva
  • Slovenia · Bosutinib Msn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ec6712de-b67f-4b70-a39a-cbf316248b71
GET /v1/drugs/ec6712de-b67f-4b70-a39a-cbf316248b71?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EMA",
    "EPAR"
  ],
  "se_npl_id": "20110825000056",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20110825000056",
  "product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/bosulif"
}

See everything about bosutinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.